How should I take BRAFTOVI?
How should I take BRAFTOVI?
- •
- Take BRAFTOVI exactly as your healthcare provider tells you. Do not change your dose or stop taking BRAFTOVI unless your healthcare provider tells you to.
- •
- For melanoma and NSCLC, BRAFTOVI is given in combination with binimetinib. Take BRAFTOVI by mouth one time each day.
- •
- For colorectal cancer, take BRAFTOVI by mouth one time each day. You will also receive cetuximab through a vein in your arm (intravenously) given by your healthcare provider.
- •
- BRAFTOVI may be taken with or without food.
- •
- Avoid grapefruit during treatment with BRAFTOVI. Grapefruit products may increase the amount of BRAFTOVI in your body.
- •
- If you miss a dose of BRAFTOVI, take it as soon as you remember. If it is within 12 hours of your next scheduled dose, take your next dose at your regular time. Do not make up for the missed dose.
- •
- Do not take an extra dose if you vomit after taking your scheduled dose. Take your next dose at your regular time.
- •
- If you stop treatment with binimetinib or cetuximab, talk to your healthcare provider about your BRAFTOVI treatment. Your BRAFTOVI dose may need to be changed or stopped.
What are the possible side effects of BRAFTOVI? BRAFTOVI may cause serious side effects, including: See "What is the most important information I should know about BRAFTOVI?" - •
- Heart problems, including heart failure. BRAFTOVI, when taken with binimetinib, can cause heart problems. Your healthcare provider will check your heart function before and during treatment with BRAFTOVI. Tell your healthcare provider right away if you get any of the following signs and symptoms of a heart problem:
- o
- feeling like your heart is pounding or racing
- o
- shortness of breath
- o
- swelling in your hands, ankles legs or feet
- o
- feeling faint or lightheaded
- •
- Liver problems. BRAFTOVI, when taken with binimetinib, can cause liver problems. Your healthcare provider will perform blood tests to check your liver function before and during treatment with BRAFTOVI. Tell your healthcare provider if you get any of the following signs and symptoms of a liver problem:
|
| - o
- yellowing of your skin or your eyes
- o
- dark or brown (tea-colored) urine
- o
- nausea or vomiting
- o
- loss of appetite
| - o
- tiredness
- o
- bruising
- o
- bleeding
|
- •
- Bleeding problems. BRAFTOVI, when taken with binimetinib or cetuximab, can cause serious bleeding problems, including in your stomach or brain, that can lead to death. Tell your healthcare provider and get medical help right away if you develop any signs of bleeding, including:
- o
- headaches, dizziness, or feeling weak
- o
- cough up blood or blood clots
- o
- vomit blood or your vomit looks like “coffee grounds”
- o
- red or black stools that look like tar
- •
- Eye problems. BRAFTOVI, when taken with binimetinib, can cause eye problems. Your healthcare provider should perform an eye exam regularly. Tell your healthcare provider right away if you develop any new or worsening symptoms of eye problems, including:
- o
- blurred vision, loss of vision, or other vision changes
- o
- see colored dots
- o
- see halos (blurred outline around objects)
- o
- eye pain, swelling, or redness
- •
- Changes in the electrical activity of your heart called QT prolongation. QT prolongation can cause irregular heartbeats that can be life threatening. Your healthcare provider should do tests before you start taking BRAFTOVI with binimetinib or cetuximab and during your treatment to check your body salts (electrolytes). Tell your healthcare provider right away if you feel faint, lightheaded, dizzy or if you feel your heart beating irregularly or fast during treatment with BRAFTOVI and binimetinib or cetuximab. These symptoms may be related to QT prolongation.
Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with BRAFTOVI if you have certain side effects. The most common side effects of BRAFTOVI when taken in combination with binimetinib for melanoma include: - •
- fatigue
- •
- nausea
- •
- vomiting
- •
- abdominal pain
- •
- pain or swelling of your joints (arthralgia)
The most common side effects of BRAFTOVI when taken in combination with cetuximab for colorectal cancer include: |
- •
- fatigue
- •
- nausea
- •
- diarrhea
- •
- acne-like rash (dermatitis acneiform)
| - •
- stomach-area (abdominal) pain
- •
- decreased appetite
- •
- pain or swelling of your joints (arthralgia)
- •
- rash
|
The most common side effects of BRAFTOVI when taken in combination with binimetinib for NSCLC include: |
- •
- fatigue
- •
- nausea
- •
- diarrhea
- •
- muscle or joint pain
- •
- vomiting
- •
- stomach-area (abdominal) pain
| - •
- blurred vision, loss of vision, or other vision changes
- •
- constipation
- •
- shortness of breath
- •
- rash
- •
- cough
|
BRAFTOVI may cause fertility problems in males. Talk to your healthcare provider if this is a concern for you. These are not all of the possible side effects of BRAFTOVI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Pfizer Inc. at 1-800-438-1985. |